This study demonstrated the broader immunosuppressive effects of HCQ treatment by counterbalancing the beneficial increase in MHC-I expression facilitated by tumor cells and undermining the direct cytotoxic responses intended by the anti-PD-1 treatment in both in vitro and in vivo models [154]. Here, PDCD1 is linked to neoplasm.